LivePerson, Inc. (NASDAQ: LPSN), a provider of real-time engagement solutions that increase conversions and improve the customer experience, today announced the official launch of LP Marketer, a real-time data-driven targeting solution that intelligently delivers relevant, personalized content to website visitors at scale. LP Marketer supports a wide range of use cases that drive business results across the customer lifecycle.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53539-liveperson-revolutionize-real-time-data-driven-personalization-lp-marketer
GE Transportation continues to harness the power of the Industrial Internet for its rail customers, while it strengthens their local economies with partnership and investment for localized manufacturing capabilities of locomotives and other rail technologies.
PowerHaul locomotives are among the most technologically advanced, fuel-efficient and low-emissions, diesel-electric locomotives in GE's fleet. Launched at InnoTrans in 2010, it has become a global platform for GE and is currently serving the United Kingdom, Korea, Australia, Europe and Turkey. Designed for high-haulage capability with lighter axle-load applications, the PowerHaul locomotive is engineered to generate more horsepower and tractive effort while lowering fuel consumption and greenhouse gas (GHG) emissions.
To see the Multimedia News Release, go to: http://www.multivu.com/players/English/7318451-ge-transportation-locomotives-data-driven-signaling-rail-operation-optimization-technology-on-display-at-innotrans-2014/
Leveraging 130 years of knowledge and expertise across the Johnson & Johnson Family of Companies, Johnson & Johnson Medical Devices (JJMD) is proud to launch a new approach to help drive value-based healthcare in hospitals across Europe, Middle East and Africa (EMEA) – CareAdvantage. This is a data-driven, holistic approach in which JJMD partners with hospitals and other healthcare providers to provide a range of benefits, tailored to the customer’s specific needs and priorities.
The healthcare marketplace is changing, with intensifying pressure to meet the ‘triple aim’ of improving outcomes, increasing patient satisfaction and reducing costs. As the focus shifts from volume to value, there is a growing need for new delivery models, resulting in rapid transformation for hospital systems, clinicians and their patients.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8119051-johnson-medical-devices-careadvantage/
Learning science company McGraw-Hill Education today announced the launch of Redbird Language Arts & Writing, a new enhanced personalized learning program that helps students master language arts concepts and build strong foundational writing skills. The new program accomplishes this by combining innovative writing analysis technology, interactive practice and personalized learning. The supplemental curriculum, for grades 2-7 and at-risk secondary students, is available to U.S. schools nationwide.
Originally developed by Stanford University, Redbird’s adaptive learning technology provides a personalized learning experience for each student. Redbird Language Arts & Writing delivers immediate feedback and charts an optimized path through the program based on each individual student’s skillset and level of progress – while also empowering educators with real-time, data-driven insights about their students’ learning.
To view the multimedia release go to:
https://www.multivu.com/players/English/7782356-mcgraw-hill-education-redbird/
UBM Tech today unveiled the new community-driven Bank Systems & Technology (banktech.com), an interactive platform for bank technology professionals to connect with peers, editors and industry experts. The redesigned site provides the latest news, commentary, and discussion on the most pressing issues that technology and business leaders face in the financial services market. More than 50 new community contributors involved in banking channel strategies, payments, security, bank core systems, data management and compliance trends will enrich its award-winning editorial coverage.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7233651-ubm-tech-unveils-new-community-driven-bank-systems-and-technology
UBM Tech today introduced the new community-driven Insurance & Technology (insurancetech.com), an interactive platform for insurance technology professionals to connect with peers, editors and industry experts. The redesigned site provides the latest news, commentary and discussion on the most pressing issues that technology and business leaders face in the insurance marketplace. Complementing the brand’s award-winning editorial is perspective from more than 50 community contributors and subject matter experts involved in channel strategies, security, data management, compliance, policy administration, claims and underwriting.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7302151-ubm-tech-introduces-the-new-insurance-and-technology-interactive-platform/
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
